Company intelligence / Profile preview
ISTA Pharmaceuticals
- Ownership
- Private
- Employees
- ~330
- Development stage
- Commercial
Overview
ISTA Pharmaceuticals was a leading US-based specialty pharmaceutical company focused on ophthalmology. It marketed several FDA-approved products for eye diseases including Bromday/Xibrom, Bepreve, Istalol, and Vitrase. At the time of its acquisition by Bausch + Lomb in June 2012 for $500 million, it was the third-largest branded prescription eye-care business in the US with an expanding portfolio targeting both approved indications and late-stage pipeline assets for dry eye, ocular inflammation/pain, and nasal allergies. The company had approximately $150 million in annual sales at acquisition[6][7].
- Therapeutic areas
- ImmunologyOphthalmology
- Modalities
- small moleculesenzyme injection
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on ISTA Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ISTA Pharmaceuticals.